FMP

FMP

Enter

APM - Aptorum Group Limite...

photo-url-https://images.financialmodelingprep.com/symbol/APM.png

Aptorum Group Limited

APM

NASDAQ

Aptorum Group Limited, a biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutic products for the treatment of infectious diseases and cancer. The company operates in the Therapeutics and Non-Therapeutics segments. Its pipeline products include SACT- 1 for neuroblastoma and other cancer types; SACT-COV19 for the treatment of coronavirus disease; ALS-4 to treat bacterial infections caused by staphylococcus aureus, including MRSA; and ALS-1 to treat viral infections caused by influenza virus A. The company is also developing ALS-2/3 for the treatment of gram+ve bacterial infections; RPIDD, a pathogen molecular diagnostic; NativusWell DOI (NLS-2), a dietary supplement; NLS-1 for the treatment of endometriosis; DLS-1+2 to treat NSCLC with mutation; DLS-3, an autoimmune small molecule; and CLS-1 for the treatment of obesity. Its pipeline products enable the discovery of new therapeutics assets, such as systematic screening of existing approved drug molecules, and microbiome-based research platforms for treatment of metabolic diseases. The company also focuses on therapeutic and diagnostic projects in neurology, gastroenterology, metabolic disorders, women's health, and other disease areas. In addition, it operates a medical clinic. Aptorum Group Limited was incorporated in 2010 and is headquartered in London, the United Kingdom.

1.12 USD

0.01 (0.893%)

Free Cash Flow

Year

2019

2020

2021

2022

2023

2024

2025

2026

2027

2028

Revenue

36.87M

17.93M

11.17M

-53.71M

14.66M

4.07M

1.13M

312.61k

86.68k

24.04k

Revenue %

-

-51.38

-37.71

-580.98

-127.3

-72.27

-72.27

-72.27

-72.27

Operating Cash Flow

26.33M

46.69M

9.69M

68.36M

27.31M

2.1M

582.08k

161.41k

44.76k

12.41k

Operating Cash Flow %

71.41

260.43

86.76

-127.27

186.29

51.63

51.63

51.63

51.63

Cap Ex

-

-

-

-

-

-

-

-

-

-

Cap Ex %

-

-

-

-

-

-

-

-

-

Free Cash Flow

26.33M

46.69M

9.69M

68.36M

27.31M

2.1M

582.08k

161.41k

44.76k

12.41k

FMP

FMP

Financial Modeling Prep API provides real time stock price, company financial statements, major index prices, stock historical data, forex real time rate and cryptocurrencies. Financial Modeling Prep stock price API is in real time, the company reports can be found in quarter or annual format, and goes back 30 years in history.
twitterlinkedinfacebookinstagram
2017-2024 © Financial Modeling Prep